In specific, the majority of cancers arising in the male breast are ER positive although this finding does not correlate with a better prognosis, as it occurs in women [14,15] Clinical responses to hormonal therapy have been observed in the ER+ patients but not in one ER – patient [16]. Here, ESR1 is linked to cancer.